Morphogen-IX competitorsClear all

Morphogen-IX's top competitors include Aralez Pharmaceuticals Canada, RespireRx Pharmaceuticals, Futura Medical and F2G.
Morphogen-IX
Morphogen-IX
Morphogen-IX is a company engaged in drug discovery.
Aralez Pharmaceuticals Canada
Aralez Pharmaceuticals Canada
Aralez Pharmaceuticals (previously known as Tribute Pharmaceuticals Canada) is a specialty pharmaceutical company.
RespireRx Pharmaceuticals
RespireRx Pharmaceuticals
RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.
Futura Medical
Futura Medical
Futura's innovation strategy applies advanced science to develop products with compelling commercial potential.
F2G
F2G
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
Founding Date
Founding Date
2015
Founding Date
1996
Founding Date
1988
Founding Date
1997
Founding Date
1998
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Babraham, GB HQ
Locations
Mississauga, CA HQ
Mississauga, CA
Dublin, IE
Locations
Glen Rock, US HQ
Locations
Guildford, GB HQ
Locations
Eccles, GB HQ
Employees
Employees
N/A
Employees
534% decrease
Employees
233% decrease
Employees
13
Employees
274% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
187.2 k
Valuation ($)
50.4 m
Valuation ($)
N/A
Twitter followers
Twitter followers
1.1 k
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
62
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
438576
Alexa Website Rank
437099
Alexa Website Rank
318350
Alexa Website Rank
193950
Alexa Website Rank
413767

Financial

Cost of goods
Cost of goods
N/A
Cost of goods
$13.5m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
£9.5m (FY, 2018)
Net income
Net income
N/A
Net income
($125.2m) (FY, 2017)
Net income
($2.1m) (FY, 2019)
Net income
(£5.9m) (FY, 2018)
Net income
£4.4m (FY, 2018)

Funding

Latest funding round
Latest funding round
$ 23.3m (about 2 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 60.8m (5 months ago)
Total funding raised
Total funding raised
$ 25.4m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 18.2m
Total funding raised
$ 213.3m
For sources of this data, please see the company profile

View company profiles

Aralez Pharmaceuticals Canada
HQ
Mississauga, CA

Aralez Pharmaceuticals (previously known as Tribute Pharmaceuticals Canada) is a specialty pharmaceutical company.

View company
RespireRx Pharmaceuticals
HQ
Glen Rock, US
Employees
2↓ 33% decrease

RespireRx Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression and other brain-mediated breathing disorders.

View company
Futura Medical
HQ
Guildford, GB
Employees
13

Futura's innovation strategy applies advanced science to develop products with compelling commercial potential.

View company
F2G
HQ
Eccles, GB
Employees
27↑ 4% increase

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

View company